Project HOPE 1000: Health Outcomes Pregnancy Exposures
Project HOPE 1000: A Longitudinal Study of Mothers and Infants to Understand Health Outcomes Related to Pregnancy and Early-Life Exposures
1 other identifier
observational
1,000
1 country
1
Brief Summary
The purpose of this study is to collect biological samples from pregnant women and their babies and to collect data on long-term health, school outcomes, and the use of state and county services. The information learned from this study may help identify important factors that may influence the health of mothers and babies, both short-and long-term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2018
CompletedFirst Submitted
Initial submission to the registry
June 2, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
ExpectedAugust 11, 2025
August 1, 2025
6 years
June 2, 2020
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Development of a data repository to provide a secure, centralized storage location for samples from pregnant women.
Up to 2 years
Study Arms (1)
Mother-infant dyads
Mother and/or infant participants will provide a series of biological specimens, including blood, urine, and microbiome samples. Additionally, each participant will wear a silicone wrist band each trimester to capture environmental exposures and will fill out study surveys related to diet, environmental exposures, and social factors.
Eligibility Criteria
Mother and/or infant participants will provide a series of biological specimens, including blood, urine, and microbiome samples. Additionally, each participant will wear a silicone wrist band each trimester to capture environmental exposures and will fill out study surveys related to diet, environmental exposures, and social factors.
You may qualify if:
- The subject has provided a signed Informed consent prior to any study procedures.
- Maternal age at consent of ≥ 18 years old
- Ability to understand English or Spanish
- Willingness to comply with and be available for all protocol procedures
- Singleton gestation \< 24 weeks 0 days
- Receiving prenatal care at a Duke-affiliated Obstetrics clinic with the intent of delivering at Duke University Health System-affiliated hospital (including Duke University Hospital and Duke Regional Hospital)
- Plans to have their infant seen at a Duke-affiliated Pediatrics practice after birth
- Plans to remain in the area for two years after delivery
You may not qualify if:
- Non-viable pregnancy
- Having any condition that, in the opinion of the site investigators, would place the subject at unacceptable risk of injury or confound data interpretation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke affiliated ObGyn clinics within Duke Health
Durham, North Carolina, 27710, United States
Biospecimen
Blood will be collected.
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Gilner, MD
Duke University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2020
First Posted
June 4, 2020
Study Start
November 21, 2018
Primary Completion
November 22, 2024
Study Completion (Estimated)
March 1, 2027
Last Updated
August 11, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share